Clinical Trial 21262

A First in Human dose escalation of Dendritic Cell Vaccine (DCV) administered Intrathecally (IT) primed against HER2/HER3 in Patients with Leptomeningeal Disease (LMD) from Triple-Negative Breast Cancer (TNBC) or HER2+ Breast Cancer (HER2+BC)

Disease Site: Brain and Nervous System

PI: Forsyth, Peter

Clinical Trial 21193

Disease Site: Brain and Nervous System, Brain metastasis

PI: Yu, Hsiang-Hsuan (Michael)

Clinical Trial 21459

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)

Disease Site: Colon

PI: Imanirad, Iman

Clinical Trial 20894

Acalabrutinib for Chronic Graft-versus-Host Disease

Disease Site: Unknown Sites

PI: Pidala, Joseph

Clinical Trial 21027

A Phase 2 Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) in Patients with Metastatic Non-Small-Cell Lung Cancer

Disease Site: Lung, Non small cell lung cancer

PI: Creelan, Benjamin

Clinical Trial 20571

Optimizing Cellular and Humoral Immunity to Pneumococcus by Vaccination with Pneumococcal 13-valent conjugate vaccine before and after CD19-targeted CAR T-cell Immunotherapy

Disease Site: Lymphoma, Non-Hodgkin's Lymphoma

PI: Locke, Frederick

Clinical Trial 21518

A Phase 1/1b Open-Label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of KIN-2787 in Participants with BRAF and/or NRAS Mutation Positive Solid Tumors

Disease Site: Any Site

PI: Kim, Richard

Clinical Trial 22333

A Phase 2, Open-Label, Ascending Dose Study of KER-050 for the Treatment of Anemia in Patients with Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

Disease Site: Leukemia, other, Myeloid and Monocytic Leukemia

PI: Komrokji, Rami

Clinical Trial 22461

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients with Hematologic Malignancies

Disease Site: Leukemia, other, Lymphoid Leukemia, Myeloid and Monocytic Leukemia

PI: Nishihori, Taiga

Clinical Trial 22463

SPECT-CT Guided Elective Contralateral Neck Treatment (Select) For Patients With Lateralized Oropharyngeal Cancer: A Phase III Randomized Controlled Trial.

Disease Site: Lip, Oral Cavity and Pharynx, Head & Neck, Mouth, lip, nasal cavity

PI: Danan, Deepa

Clinical Trial 22464

Restoration of Radioiodine Uptake with Selpercatinib in RET Fusion-Positive Radioiodine-Refractory Thyroid Cancer: A Phase 2 Study Performed in Collaboration with the International Thyroid Oncology Group (ITOG)

Disease Site: Thyroid, Head & Neck, Mouth, lip, nasal cavity

PI: Agosto Salgado, Sarimar

Clinical Trial 23101

Disease Site: Other Hematopoietic

PI: Fernandez, Hugo